Skip NavigationSkip to Content

Effect of Tumor Necrosis Factor-alpha on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance

  1. Author:
    Salama, S. A.
    Kamel, M. W.
    Diaz-Arrastia, C. R.
    Xu, X.
    Veenstra, T. D.
    Salih, S.
    Botting, S. K.
    Kumar, R.
  2. Author Address

    Salama, Salama A.] Univ Texas Med Branch Galveston, Div Gynecol Oncol, Dept Obstet & Gynecol, Galveston, TX 77555 USA. [Salama, Salama A.] Al Azahr Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt. [Kamel, Marwa W.] Cairo Univ, Dept Tumor Biol, Natl Canc Inst, Cairo, Egypt. [Xu, Xia, Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA. [Salih, Sana] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53792 USA.
    1. Year: 2009
  1. Journal: Journal of Clinical Endocrinology & Metabolism
    1. 94
    2. 1
    3. Pages: 285-293
  2. Type of Article: Article
  1. Abstract:

    Context: Estrogen and its metabolites play a critical role in the pathophysiology of the endometrium. The bioavailability of estrogen and estrogen metabolites in endometrial tissues depends on the expression of enzymes involved in estrogen biosynthesis and metabolism. Substantial evidence indicates that estrogen-dependent endometrial disorders are also associated with proinflammatory milieu. However, the mechanism whereby inflammation contributes to these conditions is not known. Objective: The objective of the study was to investigate the effect of TNF-alpha on estrogen metabolism and the expression of estrogen-metabolizing genes inhuman endometrial glandular epithelial cells (EM1). Design: EM1 were treated with 17 beta-estradiol (E2) with or without TNF-alpha. Capillary liquid chromatography-tandem mass spectrometry analysis was used for quantitative measurement of estrogens and estrogen metabolites. Western blot analysis, reporter gene assay, and real-time RT-PCR were used to assess the expression of estrogen-metabolizing genes. Results: TNF-alpha treatment significantly increased the level of total estrogen and estrogen metabolites and significantly increased the rate of conversion of estrone (E1) into E2. TNF-alpha also enhanced the oxidative metabolism of estrogen into catecholestrogens with concomitant inhibition of their conversion into methoxyestrogens. Gene expression analysis revealed that TNF-alpha induced the expression of genes involved in E2 biosynthesis (steroidogenic factor-1 and aromatase) and activation (17 beta-hydroxysteroid dehydrogenase type 1 and cytochrome P-450, 1B1) with simultaneous repression of genes involved in estrogen inactivation (17 beta-hydroxysteroid dehydrogenase type 2, catechol O-methyltransferase, and nicotinamide adenine dinucleotide phosphate-quinone oxidoreductase 1). Conclusion: TNF-alpha increases the local estrogen biosynthesis in human endometrial glandular cells and directs estrogen metabolism into more hormonally active and carcinogenic metabolites. These effects may impact many physiological and pathological processes that occur within the endometrium. (J Clin Endocrinol Metab 94: 285-293, 2009)

    See More

External Sources

  1. PMID: 18957495

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel